 | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (3) | : | IDXHEALTH, COMPOSITE, ISSI | ||
| Index (3) | : | IDXHEALTH, COMPOSITE, ISSI | ||
| Board | : | 3 Index IDXHEALTH, COMPOSITE, ISSI | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | Cum Dividen | ||
| Special Notation | : | Perusahaan Tercatat memenuhi kriteria Efek Bersifat Ekuitas Dalam Pemantauan Khusus. | ||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | |
|||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 4 | |
| Rating ROA | 3 | |
| Rating EQUITY | 4 | |
| Rating ROE | 3 | |
| Rating DER | 4 | |
| Rating TOTAL | 4 | |
| MARKET CAPITALIZATION | ||
| Listed Share | 3.600.000 | |
| Price | Rp. 29.000 | |
| Capitalization | Rp. 104.400.000.000 | |
| OWNERSHIP | ||
| Listing Date : 08-Jun-90 | ||
| Lokal 0,15 % | Asing 98,79 % | Lainnya 1,06 % |
| SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (3) | : | IDXHEALTH, COMPOSITE, ISSI | ||
| Index (3) | : | IDXHEALTH, COMPOSITE, ISSI | ||
| Board | : | 3 Index IDXHEALTH, COMPOSITE, ISSI | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | Cum Dividen | ||
| Special Notation | : | Perusahaan Tercatat memenuhi kriteria Efek Bersifat Ekuitas Dalam Pemantauan Khusus. | ||
Financial Statements
| Description | 3Q17 | 3Q18 | 3Q19 | 3Q20 | 3Q21 | 3Q22 | 3Q23 | CAGR 5Y(%) |
| Last Price | 1155 | 1545 | 1800 | 700 | 1030 | 1140 | 1145 | |
| Market Cap | 3.0 T | 4.1 T | 4.8 T | 1.8 T | 2.7 T | 3.0 T | 3.0 T | -26.83 |
| BALANCE SHEET | ||||||||
| Cash | 476.5 B | 191.0 B | 396.3 B | 274.8 B | 558.7 B | 460.5 B | 368.0 B | 92.67 |
| Total Asset | 3.0 T | 4.2 T | 5.0 T | 4.8 T | 5.0 T | 6.0 T | 7.7 T | 83.33 |
| S.T.Borrowing | 1.4 T | 2.1 T | 2.3 T | 1.9 T | 1.7 T | 2.2 T | 1.9 T | |
| L.T.Borrowing | 190.7 B | 160.2 B | 119.9 B | 128.5 B | 145.9 B | 144.3 B | 1.5 T | |
| Total Equity | 1.4 T | 1.9 T | 2.5 T | 2.7 T | 3.2 T | 3.7 T | 4.3 T | 126.32 |
| INCOME STATEMENT | ||||||||
| Revenue | 1.5 T | 3.0 T | 4.9 T | 2.8 T | 2.8 T | 2.4 T | 3.9 T | 30.00 |
| Gross Profit | 234.8 B | 635.0 B | 777.4 B | 524.5 B | 489.7 B | 428.2 B | 608.0 B | -4.25 |
| Operating Profit | 138.9 B | 525.4 B | 675.1 B | 401.9 B | 373.4 B | 317.9 B | 482.9 B | -8.09 |
| Net.Profit | 151.2 B | 386.5 B | 554.1 B | 303.4 B | 301.7 B | 332.1 B | 513.1 B | 32.76 |
| EBITDA | 146.0 B | 536.4 B | 689.5 B | 540.5 B | 488.8 B | 422.7 B | 564.8 B | 5.29 |
| Interest Expense | 34.9 B | 71.2 B | 63.2 B | 64.5 B | 61.3 B | 33.9 B | 39.8 B | |
| RATIO | ||||||||
| EPS | 58.14 | 148.67 | 213.12 | 116.69 | 116.02 | 127.73 | 197.34 | 32.74 |
| PER | 19.87 x | 10.39 x | 8.45 x | 6.00 x | 8.88 x | 8.93 x | 5.80 x | |
| BVPS | 522.67 | 736.21 | 955 | 1039.57 | 1193.75 | 1397.11 | 1642.94 | |
| PBV | 2.21 x | 2.10 x | 1.88 x | 0.67 x | 0.86 x | 0.82 x | 0.70 x | |
| ROA | 0.0507 | 0.0923 | 0.1111 | 0.0631 | 0.0601 | 0.0553 | 0.0663 | -28.17 |
| ROE | 0.1095 | 0.1988 | 0.2197 | 0.1105 | 0.0957 | 0.09 | 0.1183 | -40.49 |
| EV/EBITDA | 28.6 | 11.43 | 9.89 | 6.72 | 8.25 | 11.52 | 10.73 | |
| Debt/Equity | 1.16 | 1.15 | 0.98 | 0.75 | 0.59 | 0.63 | 0.79 | |
| Debt/TotalCap | 0.54 | 0.54 | 0.49 | 0.43 | 0.37 | 0.39 | 0.44 | |
| Debt/EBITDA | 10.97 | 4.18 | 3.58 | 3.81 | 3.83 | 5.49 | 6.03 | |
| EBITDA/IntExps | 4.19 | 7.53 | 10.91 | 8.38 | 7.97 | 12.45 | 14.19 | 88.45 |
| Deviden | ||||||||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | |
|||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| MARKET CAPITALIZATION | ||
| Listed Share | 3.600.000 | |
| Price | Rp. 29.000 | |
| Capitalization | Rp. 104 B. | |
| OWNERSHIP | ||
| Listing Date : 08-Jun-90 | ||
| Lokal 0,15 % | Asing 98,79 % | Lainnya 1,06 % |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 4 | |
| Rating ROA | 3 | |
| Rating EQUITY | 4 | |
| Rating ROE | 3 | |
| Rating DER | 4 | |
| Rating TOTAL | 4 | |
RETURN ON ASSET
| SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (3) | : | IDXHEALTH, COMPOSITE, ISSI | ||
| Index (3) | : | IDXHEALTH, COMPOSITE, ISSI | ||
| Board | : | 3 Index IDXHEALTH, COMPOSITE, ISSI | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | Cum Dividen | ||
| Special Notation | : | Perusahaan Tercatat memenuhi kriteria Efek Bersifat Ekuitas Dalam Pemantauan Khusus. | ||
| TIME PERIOD : 29-11-2023 | |||
| Close | 29000 | Prev Close | 29000 |
| Change | - | Range | 0-0 |
| Bid | 0 | Offer | 0 |
| Bid Volume | 0 | Offer Volume | 0 |
| Frequency | 0 | Value Rp.: 0 | |
| RETURN ON ASSET | |||||
|---|---|---|---|---|---|
| Benchmark to Others : | |||||
| A Exceptional | |||||
| B Excellent | |
||||
| C Very Good | |||||
| D Good | |||||
| E Fair | |||||
| F Poor | |||||
| RATIO (%) | ≤ 0 |
0-0.4 | 0.4- 1.7 |
1.7- 3.6 |
> 3.6 |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | |
|||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
